NIH-funded research R01 grant

How problems with cholesterol regulation and cell recycling contribute to pancreatitis

Official title: Dysregulated cholesterol homeostasis, caused by lysosomal/autophagy dysfunction, mediates pancreatitis

Funded at University of California Los Angeles · NIH-11000340 · Data updated 2026-11-12

This study is looking at how problems with certain cell processes might contribute to acute pancreatitis, a serious condition, and it’s testing whether cholesterol-lowering medications like statins can help improve the health of the pancreas, which could lead to better treatments for this condition.

More Pancreatitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startApril 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$319,335
NIH project number5R01DK131493-03
Project IDNIH-11000340 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from acute pancreatitis or those at risk of developing this condition.

Less likely to help

Patients with chronic pancreatitis or those whose pancreatitis is not related to cholesterol metabolism may not benefit from this research.

What this research studies

This research investigates the role of lysosomal and autophagy dysfunction in the development of acute pancreatitis, a serious condition with few treatment options. It explores how these cellular processes affect cholesterol homeostasis in acinar cells, which are crucial for pancreatic function. By examining the effects of cholesterol-lowering drugs like statins on these cells, the study aims to uncover new mechanisms that may lead to better understanding and treatment of pancreatitis. The research combines genetic studies and drug response assessments to identify potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for acute pancreatitis, improving patient outcomes and reducing mortality.

How similar studies have gone: Previous studies have shown that targeting cholesterol metabolism can influence pancreatitis outcomes, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Gukovskaya, Anna S. — University of California Los Angeles
  • Study coordinator: Gukovskaya, Anna S.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.